Clinical effects of surgical resection of osteosarcoma in proximal fibula and long-term follow-up of health status

Zimei  Liu; Dingyu  Zhu; Zhenzhen  Liu; Lei  Jin

doi:10.18282/po3655

Zimei Liu Department of Oncology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200336, China
Dingyu Zhu Department of Nephrology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200336, China
Zhenzhen Liu Department of Respiratory Medicine, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200336 China
Lei Jin Department of Rheumatology, Immunology & Allergy, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China

Article ID: 3655

93 Views

DOI: https://doi.org/10.18282/po3655

Keywords: osteosarcoma; proximal fibula; SF-36; psychology

Abstract

Purpose: This study aimed to evaluate the health status and quality of life in patients with osteosarcoma of the proximal fibula following surgical treatment. The procedure necessarily involved resection of the peroneal nerve, resulting in iatrogenic footdrop. Methods: From January 2005 to 26 August 2020 patients with osteosarcoma in the proximal fibula were treated at the oncology department of Shanghai Jiao Tong University Affiliated Sixth People’s Hospital. Clinical-pathological features as well as outcomes of these patients were investigated. Meanwhile, to clarify their health status, the SF-36 health survey questionnaire was administered at 12, 24, and 36 months post-diagnosis. Results: The outcomes for patients with osteosarcoma in the proximal fibula were encouraging. Both the three-year disease-free survival rate and the overall survival rate were recorded at 88.5% (23/26). Data from the SF-36 health survey questionnaire, completed by 20 patients who underwent limb-sparing surgery, revealed that at 24 months, patients perceived themselves as less healthy, both physically and emotionally, compared to their status at 12 months. Despite observing significant recovery at 36 months, the health status did not return to the levels reported at 12 months. The majority of patients (n = 17) identified “footdrop after surgery” as the primary factor affecting their quality of life. Conclusions: Osteosarcomas affecting the proximal fibula typically demonstrate a favorable prognosis following multi-modal treatment. However, patients’ health status, including psychological well-being, requires improvement. Oncologists should strive to achieve an “equilibrium point” that minimizes the risk of recurrence while preserving peroneal nerve function.

References

Freedman IG, Dowd HN, Dhodapkar MM, et al. Second primary malignancies of the bones and joints: More common than expected in osteosarcoma patients. Am. Acad. Orthop. Surg. Glob. Res. Rev. 2023; 7(1).

Saadon I, Amit B, Zolquarnian A, Muhamad F. Primary osteosarcoma of the distal fibula treated with distal fibulectomy with a five-year follow-up: A case report. Malays. Orthop. J. 2017; 11(2): 64–67.

Muslu O, Cengiz T, Şimşek SA, et al. Osteosarcoma of the proximal fibula: A case report and review of the literature. Cureus. 2023; 15(4): e38195.

Pu F, Yu Y, Zhang Z, et al. Clinical effect of surgical resection on primary malignant and invasive bone tumours of the proximal fibula. Mol. Clin. Oncol. 2023; 18(4): 27.

Lushiku HB, Gebhart M. Osteosarcoma of the proximal fibula: Report of 3 cases. Acta. Chir. Belg, 1997; 97(5): 260–263.

Malawer MM. Surgical management of aggressive and malignant tumors of the proximal fibula. Clin. Orthop. Relat. Res. 1984; 186: 172–181.

Natarajan M, Paraskumar M, Rajkumar G, et al. Limb salvage in aggressive and malignant tumours of the fibula. Int. Orthop. 2004; 28(5): 307–310.

Kanazawa Y, Tsuchiya H, Nonomura A, et al. Intentional marginal excision of osteosarcoma of the proximal fibula to preserve limb function. J. Orthop. Sci. 2003; 8(6): 757–761.

Ozaki T, Hillmann A, Lindner N, Winkelmann W. Surgical treatment of bone sarcomas of the fibula. Analysis of 19 cases. Arch. Orthop. Trauma. Surg. 1997; 116(8): 475–479.

Hayashi K, Tsuchiya H, Yamamoto N, et al. Functional outcome in patients with osteosarcoma around the knee joint treated by minimised surgery. Int. Orthop. 2008; 32(1): 63–68.

Yan TQ, Yang RL, Guo W. The clinical outcome of proximal fibular osteosarcoma with en-bloc resection. Zhonghua Wai Ke Za Zhi. 2008; 46(9): 661–663.

Pranikoff S, Miller VLA, Heiling H, et al. Frail young adult cancer survivors experience poor health-related quality of life. Cancer. 2022; 128(12): 2375–2383.

Vargo MM. Outcome measures and patient-reported metrics in cancer rehabilitation. Curr. Oncol. Rep. 2023; 25(8): 869–882.

Munshi L, Dumas G, Rochwerg B, et al. Long-term survival and functional outcomes of critically ill patients with hematologic malignancies: A Canadian multicenter prospective study. Intensive Care Med. 2024; 50(4): 561–572.

LeBlanc MR, Zimmerman S, LeBlanc TW, et al. Persistent fatigue among long-term non-Hodgkin lymphoma survivors. Leuk. Lymphoma. 2022; 63(2): 344–352.

Stefanski KJ, Anixt JS, Goodman P, et al., Long-Term neurocognitive and psychosocial outcomes after acute myeloid leukemia: A childhood cancer survivor study report. J. Natl. Cancer Inst. 2021; 113(4): 481–495.

Madenci AL, Dieffenbach BV, Liu Q, et al., Late-onset anorectal disease and psychosocial impact in survivors of childhood cancer: A report from the childhood cancer survivor study. Cancer. 2019; 125(21): 3873–3881.

Lin F, Wang Q, Yu W, et al. Clinical analysis of Chinese limb osteosarcoma patients treated by two combinations of methotrexate, cisplatin, doxorubicin and ifosfamide. Asia. Pac. J. Clin. Oncol. 2011; 7(3): 270–275.

Enneking WF, Dunham W, Gebhardt MC, et al. A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clin. Orthop. Relat. Res. 1993; 286: 241–246.

Robert RS, Ottaviani G, Huh WW, et al. Psychosocial and functional outcomes in long-term survivors of osteosarcoma: A comparison of limb-salvage surgery and amputation. Pediatr Blood Cancer. 2010; 54(7): 990–999.